🏥
Public Health
What the Latest Research Reveals
Data last updated: 26 studies cited
How this page is produced
Generated by the ModernDoc Research Monitor from peer-reviewed literature. Every statistic is automatically checked against its cited source and screened for retractions before it is published. This page is AI-generated and has not yet been reviewed by a clinician — it is not medical advice. Read how we build and check these pages.
14-20M
Lives saved by COVID-19 vaccination in first year alone
— global impact of vaccine rollout
Source: Watson et al.. Lancet Infectious Diseases (2022). 10.1016/S1473-3099(22)00320-60
KEY FINDINGS
Excess Mortality
14.9-28.1M
95% CI: Global excess deaths 2020-2023 (95% CI)
Source [1]
Health Disparity
2.3x
95% CI: Hispanic vs White mortality ratio (age-adjusted)
Source [2]
Long COVID Prevalence
6-12%
95% CI: Post-infection persistent symptoms (varies by definition)
Source [3]
Vaccine Effectiveness
90-95%
95% CI: mRNA VE against symptomatic infection (95% CI: 88-97%)
Source [4]
Pooled prevalence of prolonged grief disorder during COVID-19 pandemic
24%
95% CI: 95% CI: 13%-36%
Source [25]
PGD prevalence in China, highest among studied regions
43%
95% CI: 95% CI: 33%-54%
Source [25]
PGD prevalence by diagnostic criteria: DSM-5-TR vs ICD-11
18% vs. 26%
Source [25]
Vaccine effectiveness against COVID-19-associated ED/UC encounters
50%
95% CI: 95% CI: 42%-57%
Source [26]
Vaccine effectiveness against COVID-19-associated hospitalization
55%
95% CI: 95% CI: 41%-66%
Source [26]
Vaccine effectiveness against ED/UC encounters in adults aged 65+
48%
95% CI: 95% CI: 37%-56%
Source [26]
Vaccine effectiveness against hospitalization in adults aged 65+
53%
95% CI: 95% CI: 37%-65%
Source [26]
THE TIMELINE
Acute Phase
0-4 weeks
Subacute Phase
4-12 weeks
Chronic Phase
3-12 months
Long-Term
>12 months
Acute Phase
0-4 weeks
Days 1-5 of symptoms; hospitalization Days 5-10
Key Event
Peak viral transmission
Life Expectancy Change
Pre-Pandemic US (2019)78.8 years
During Pandemic (2021)76.4 years
Source: CDC NVSS - 2.4 year decline
Cumulative Risk with Reinfection
1 infection+Baseline
2 infections+HR 2.17 mortality
3+ infections+HR 3.32 hospitalization
“Each reinfection adds incremental risk with no evidence of protective training effect”
THE HOPEFUL HORIZON
- Vaccination prevented 14-20 million deaths globally in 2021 alone[4]
- mRNA vaccines maintained 85-95% effectiveness against death across all variants[6]
- Hybrid immunity (infection + vaccination) provides most robust protection[7]
- Variant-updated boosters show improved neutralizing antibody responses[8]
SOURCES
- [1]Wang H, Paulson KR, Pease SA, et al. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet. 2022;399(10334):1513-1536. DOI (opens in new tab)
- [2]APM Research Lab. The color of coronavirus: COVID-19 deaths by race and ethnicity in the U.S. Updated 2021.
- [3]Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology. 2023;21(3):133-146. DOI (opens in new tab)
- [4]Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603-2615. DOI (opens in new tab)
- [5]Al-Aly Z, Bowe B, Xie Y. Outcomes of SARS-CoV-2 Reinfection. Nature Medicine. 2022;28(11):2398-2405. DOI (opens in new tab)
See a problem with the Public Health research summary?
Send a source correction or freshness concern. We cannot provide personal medical advice through this site.
Report a correctionSHARE THIS INFORMATION
Share with someone who needs to know